Furthermore, there was a statistically significant correlation between CYP3A5 expression and tumor response to irinotecan therapy, suggesting a tumor-autonomous resistance to the treatment through increased CYP3A5-mediated metabolism [95]. Here, CYP3A5 is linked to neoplasm.